
Results: The 5-year relative survival rate at the time of diagnosis was 61.1% for all cases. CRS rates were calculated stratified by age at diagnosis, cancer stage, histology, treatment received, year of diagnosis, and social deprivation index. Patients diagnosed with ovarian cancer between 19 were included. Methods: This nationwide retrospective cohort study used data from the Korean Central Cancer Registry. We aimed to present the 5-year relative conditional survival probabilities of patients diagnosed with ovarian cancer from 1997–2016. Objective: Conditional relative survival (CRS) rates, which take into account changes in prognosis over time, are useful estimates for survivors and their clinicians as they make medical and personal decisions.

2Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.1Supportive Care Center/Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.Dong Wook Shin 1,2, Jaeman Bae 3*, Johyun Ha 4,5 and Kyu-Won Jung 4,5*
